Viewing data from:

RIZATRIPTAN BENZOATE

ANDA

RIZATRIPTAN BENZOATE | A203146 | MACLEODS PHARMACEUTICALS LTD

2 strengths0 unique patents0 unique exclusivities

Reference Listed Drug: MAXALT-MLT(TE code: AB)

Drug Pricing (NADAC)

National Average Drug Acquisition Cost — Week of 2026-07-15 | 5 NDCs

Highest NADAC/Unit

$0.5293

per ea

Lowest NADAC/Unit

$0.5086

per ea

Brand NDCs

Generic NDCs

NDC Description	NADAC/Unit	Unit	Type	Generic NADAC	Effective
33342009441RIZATRIPTAN 10 MG ODT	$0.5293	EA	Generic	—	2026-06-17
33342009452RIZATRIPTAN 10 MG ODT	$0.5293	EA	Generic	—	2026-06-17
33342009341RIZATRIPTAN 5 MG ODT	$0.5086	EA	Generic	—	2026-06-17
33342009345RIZATRIPTAN 5 MG ODT	$0.5086	EA	Generic	—	2026-06-17
33342009352RIZATRIPTAN 5 MG ODT	$0.5086	EA	Generic	—	2026-06-17

Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.

API Supply Chain19 active DMFs3 inactive

18 active API suppliers hold Drug Master Files for this ingredient.

CIPLA LTDRIZATRIPTAN BENZOATE USP

DMF 180212005

MATRIX PHARMACORP PRIVATE LTDRIZATRIPTAN BENZOATE USP

DMF 190982006

DR REDDYS LABORATORIES LTDRIZATRIPTAN BENZOATE USP

DMF 191792006

NATCO PHARMA LTDRIZATRIPTAN BENZOATE

DMF 207812007

ALIVUS LIFE SCIENCES LTDRIZATRIPTAN BENZOATE USP

DMF 226762009

NATCO PHARMA LTDRIZATRIPTAN BENZOATE (ROUTE - 2; PRODUCT CODE: RTB)

DMF 227632009

SMS PHARMACEUTICALS LTDRIZATRIPTAN BENZOATE

DMF 230662009

SUN PHARMACEUTICAL INDUSTRIES LTDRIZATRIPTAN BENZOATE USP

DMF 235812010

ZHEJIANG SUPOR PHARMACEUTICALS CO LTDRIZATRIPTAN BENZOATE

DMF 235982010

APITORIA PHARMA PRIVATE LTDRIZATRIPTAN BENZOATE USP (NON-STERILE DRUG SUBSTANCE)

DMF 238142010

JUBILANT BIOSYS LTDRIZATRIPTAN BENZOATE USP

DMF 240542010

UNIMARK REMEDIES LTDRIZATRIPTAN BENZOATE

DMF 241772010

MACLEODS PHARMACEUTICALS LTDRIZATRIPTAN BENZOATE

DMF 245522011

ALKEM LABORATORIES LTDRIZATRIPTAN BENZOATE USP

DMF 248842011

INKE SARIZATRIPTAN BENZOATE

DMF 256232011

EMCURE PHARMACEUTICALS LTDRIZATRIPTAN BENZOATE USP

DMF 257642012

HETERO DRUGS LTDRIZATRIPTAN BENZOATE USP

DMF 260172012

UNICHEM LABORATORIES LTDRIZATRIPTAN BENZOATE USP

DMF 279912014

SYN-TECH CHEM AND PHARM CO LTDRIZATRIPTAN BENZOATE USP

DMF 286342014

CIPLA LTDInactiveRIZATRIPTAN BENZOATE

DMF 176332004

APOTEX PHARMACHEM INDIA PVT LTDInactiveRIZATRIPTAN BENZOATE USP

DMF 240612010

ALP PHARM BEIJING CO LTDInactiveRIZATRIPTAN BENZOATE

DMF 252292011

Source: FDA Drug Master Files (fda.gov). Type II API DMFs matched by ingredient.

Approval Letters

1 letter from Drugs@FDA

Date	Submission	Document
Sep 23, 2014	ORIG -1	View Letter (PDF)

Source: Drugs@FDA application documents.

Products (2)

Sort:

#001 — EQ 5MG BASE

0 patents0 exclusivities▴

TABLET, ORALLY DISINTEGRATING;ORAL | Approved: Sep 19, 2014

No patent or exclusivity listings for this strength.

#002 — EQ 10MG BASE

0 patents0 exclusivities▾

TABLET, ORALLY DISINTEGRATING;ORAL | Approved: Sep 19, 2014